» Articles » PMID: 19023425

Viral Load, Clinical Disease Severity and Cellular Immune Responses in Primary Varicella Zoster Virus Infection in Sri Lanka

Overview
Journal PLoS One
Date 2008 Nov 22
PMID 19023425
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In Sri Lanka, varicella zoster virus (VZV) is typically acquired during adulthood with significant associated disease morbidity and mortality. T cells are believed to be important in the control of VZV replication and in the prevention of reactivation. The relationship between viral load, disease severity and cellular immune responses in primary VZV infection has not been well studied.

Methodology: We used IFNgamma ELISpot assays and MHC class II tetramers based on VZV gE and IE63 epitopes, together with quantitative real time PCR assays to compare the frequency and phenotype of specific T cells with virological and clinical outcomes in 34 adult Sri Lankan individuals with primary VZV infection.

Principal Findings: Viral loads were found to be significantly higher in patients with moderate to severe infection compared to those with mild infection (p<0.001) and were significantly higher in those over 25 years of age (P<0.01). A significant inverse correlation was seen between the viral loads and the ex vivo IFNgamma ELISpot responses of patients (P<0.001, r = -0.85). VZV-specific CD4+ T cells expressed markers of intermediate differentiation and activation.

Conclusions: Overall, these data show that increased clinical severity in Sri Lankan adults with primary VZV infection associates with higher viral load and reduced viral specific T cell responses.

Citing Articles

From cradle to late life: Chicken pox in a sixty-one year old man.

Shemshadi M, Davoodi L, Taheri A IDCases. 2025; 39:e02153.

PMID: 39896793 PMC: 11787590. DOI: 10.1016/j.idcr.2025.e02153.


Potent and long-lasting humoral and cellular immunity against varicella zoster virus induced by mRNA-LNP vaccine.

Bhattacharya A, Jan L, Burlak O, Li J, Upadhyay G, Williams K NPJ Vaccines. 2024; 9(1):72.

PMID: 38575581 PMC: 10995133. DOI: 10.1038/s41541-024-00865-5.


Immunogenicity in Mice Immunized with Recombinant Adenoviruses Expressing Varicella-Zoster Virus Envelope Glycoprotein E.

Zheng Y, Huang L, Ding H, Xu H, Shu R, Yu J Viruses. 2023; 15(12).

PMID: 38140528 PMC: 10747211. DOI: 10.3390/v15122288.


Unusual herpetic reactivation in a young female following botox injection: a case report study.

Amini-Salehi E, Eslami N, Tamimi A, Sedighi N, Moghdam S, Yaghubi-Kalurazi T BMC Infect Dis. 2023; 23(1):647.

PMID: 37784014 PMC: 10546652. DOI: 10.1186/s12879-023-08514-3.


Safety and immunogenicity of a skin- and neuro-attenuated live vaccine for varicella: a randomized, double-blind, controlled, dose-escalation and age de-escalation phase 1 clinical trial.

Mo Z, Huang S, Qiu L, Li C, Yu X, Li M Lancet Reg Health West Pac. 2023; 34:100707.

PMID: 37283962 PMC: 10240365. DOI: 10.1016/j.lanwpc.2023.100707.


References
1.
de Jong M, Weel J, Schuurman T, BOOM R . Quantitation of varicella-zoster virus DNA in whole blood, plasma, and serum by PCR and electrochemiluminescence. J Clin Microbiol. 2000; 38(7):2568-73. PMC: 86970. DOI: 10.1128/JCM.38.7.2568-2573.2000. View

2.
Patel P, Yoonessi S, OMalley J, Freeman A, Gershon A, Ogra P . Cell-mediated immunity to varicella-zoster virus infection in subjects with lymphoma or leukemia. J Pediatr. 1979; 94(2):223-30. DOI: 10.1016/s0022-3476(79)80828-8. View

3.
Smith J, Liu X, Kaufhold R, Clair J, Caulfield M . Development and validation of a gamma interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus. Clin Diagn Lab Immunol. 2001; 8(5):871-9. PMC: 96163. DOI: 10.1128/CDLI.8.5.871-879.2001. View

4.
Ito Y, Kimura H, Hara S, Kido S, Ozaki T, Nishiyama Y . Investigation of varicella-zoster virus DNA in lymphocyte subpopulations by quantitative PCR assay. Microbiol Immunol. 2001; 45(3):267-9. DOI: 10.1111/j.1348-0421.2001.tb02617.x. View

5.
Vazquez M, LaRussa P, Gershon A, Steinberg S, Freudigman K, Shapiro E . The effectiveness of the varicella vaccine in clinical practice. N Engl J Med. 2001; 344(13):955-60. DOI: 10.1056/NEJM200103293441302. View